Related Experiment Video

Updated: May 23, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial

So-Hee Eun1, Baik-Lin Eun, Joon Soo Lee

  • 1Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.

Brain & Development
|April 24, 2012
PubMed

Insights

Lamotrigine (LTG) and carbamazepine (CBZ) showed similar efficacy for pediatric epilepsy. Carbamazepine demonstrated greater benefits in improving externalizing behaviors in children.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Pediatric epilepsy requires effective monotherapy with careful consideration of cognitive and behavioral side effects.
  • Lamotrigine (LTG) and carbamazepine (CBZ) are commonly used antiepileptic drugs (AEDs) for partial-onset seizures in children.

Purpose of the Study:

  • To compare the cognitive and behavioral effects of lamotrigine (LTG) versus carbamazepine (CBZ) as monotherapy in children with newly diagnosed epilepsy.
  • To assess and compare the antiepileptic efficacy and tolerability of LTG and CBZ.

Main Methods:

  • A multicenter, randomized, open-label, parallel-group trial involving children with partial-onset seizures.
  • Participants received either LTG or CBZ monotherapy, titrated over 8 weeks, followed by a 24-week maintenance phase.
  • Cognitive and behavioral changes were assessed using standardized measures; antiepileptic efficacy and tolerability were also evaluated.

Main Results:

  • Seizure-free rates were comparable between LTG and CBZ groups (53.5% vs. 56.1%, p=0.81).
  • No significant differences in intelligence were observed between the groups post-treatment.
  • Parental reports (Conner scale) indicated improvement in externalizing behaviors with CBZ compared to LTG (p<0.05).

Conclusions:

  • Lamotrigine and carbamazepine exhibit similar efficacy and cognitive profiles for treating pediatric partial epilepsy.
  • Carbamazepine may offer additional benefits by improving externalizing behavioral problems in this population.

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...